Evidence map›Paper›PMID 37443813›Full record

ReviewCells2023

Autophagy in Crohn's Disease: Converging on Dysfunctional Innate Immunity.

Kibrom M Alula, Arianne L Theiss

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Selenium: A Key Element in Inflammatory Bowel Disease.Antioxidants (Basel, Switzerland) · 2025
    Review
  10. Article
  11. Article
  12. Biological Modulation of Autophagy by Nanoplastics: A Current Overview.International journal of molecular sciences · 2025
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Autophagy and its role in gastrointestinal diseases.World journal of gastroenterology · 2024
    Article
  18. Mitochondrial function and gastrointestinal diseases.Nature reviews. Gastroenterology & hepatology · 2024
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kibrom M AlulaDivision of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0002-1960-7617
Arianne L TheissDivision of Gastroenterology & Hepatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.ORCID 0000-0003-2862-0933
University of Colorado Anschutz Medical Campus · US

Funding

Mitochondrial Dysfunction and Mitophagy in IleitisR01DK117001 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI THEISS, ARIANNE L · 2018 to 2022
$1.9M
NIDDK NIH HHS R01 DK117001NIDDK NIH HHS R01-DK117001
6 · The paper itself

Abstract

Crohn's disease (CD) is a chronic inflammatory bowel disease marked by relapsing, transmural intestinal inflammation driven by innate and adaptive immune responses. Autophagy is a multi-step process that plays a critical role in maintaining cellular homeostasis by degrading intracellular components, such as damaged organelles and invading bacteria. Dysregulation of autophagy in CD is revealed by the identification of several susceptibility genes, including

Indexed as

Crohn DiseaseInflammatory Bowel DiseasesAutophagyHumansImmunity, InnateIntestinesATG16L1Crohn’s diseaseER stressgenetic susceptibilityinflammatory bowel diseaseinnate immunityIRGMmitochondriamitophagyNOD2xenophagy

Identifiers

PMID37443813
PMCPMC10341259
OpenAlexW4383226806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.